Most Recent
A class action over AMP's fees for no service practice wants communications with law firm Clayton Utz that led up to a report that allegedly went through 25 rounds of edits with the wealth manager's inhouse lawyers before being presented to the corporate regulator as independent.
Investors in Mayfair Group’s collapsed IPO Wealth Fund have clawed back only a fraction of their alleged $67 million losses after a judge approved a settlement in a class action alleging the fund’s trustee misled unit holders.
A former special forces commander who has sued the Australian Broadcasting Corporation over stories that allegedly imply he committed war crimes in Afghanistan is seeking to throw out the broadcaster’s truth defence, a court has heard.
US-based mozzarella giant Leprino Foods has succeeded in removing Canadian dairy company Saputo's 'Ascend' trade mark for non-use.
A $13 million commission sought by the funder that bankrolled the Opal Tower class action is stalling settlement approval, as debate continues over whether the funder can recoup the costs of after-the-event insurance from group members.
PTTEP Australia's appeal of a class action finding that it breached a duty of care to thousands of farmers impacted by the 2009 Montara oil spill has been put on hold amid a fight between the funder and lawyers that is cloaked in confidentiality.
A consortium of parmigiano reggiano producers has lost its challenge to Kraft Foods’ 'Kraft parmesan cheese' trade mark after an IP Australia delegate found that customers would be “sceptical” that the product was Italian.
Workplace relations heavyweight Employsure has suffered a partial defeat in appeals brought by rival ELMO Software and two former employees seeking to jump ship to a competitor.
A judge has refused a bid by manufacturer Howden to use an expert report before IP Australia in a dispute accusing rival Minetek of misappropriating confidential information for an industrial fan patent, saying it was “wasteful” when a similar dispute was already before the court.
US medical device manufacturer Boston Scientific has withdrawn a controversial gag clause from of its $105 million deal to settle a class action by women allegedly injured by pelvic mesh devices after a judge raised concerns about its legality.